---
DrugClass: "[[Menopause and Andropause Drugs]]"
SubClass: "[[Antispasmatics]]"
DrugClassAdverse: "[[Antispasmatics#Adverse Reactions]]"
DrugClassContra: "[[Antispasmatics#Contraindications]]"
BrandName: Myrbetriq
SecondaryDrugClass: 
SecondarySubClass: 
SecondaryAdverse: 
SecondaryContra: 
ThirdDrugClass: 
ThirdSubClass: 
ThirdAdverse: 
ThirdContra: 
FourthDrugClass: 
FourthSubClass: 
FourthAdverse: 
FourthContra: 
Chapter: "45"
KindleLinkChap: "[Chapter 45](kindle://book?action=open&asin=B09FRF11YJ&location=26138)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
aliases: 
SubCat:
---
```smiles
C1=CC=C(C=C1)[C@H](CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
OAB w/ urge incontinence, urgency/ frequency
25 mg orally daily, titrate up to 50 mg/ day

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action


### Side/Adverse Effects
See `= this.DrugClassAdverse`
Constipation, diarrhea, dizziness, nausea

### Interactions

`= this.ChemLink+this.file.name`
